Objective: The analysis of cancer trends in Japan has only been sporadically reported. We present a comprehensive report on the trends in cancer incidence and mortality in Japan using the most recent population-based data. Methods: National cancer mortality data between 1958 and 2011 were obtained from published vital statistics. Cancer incidence data between 1985 and 2007 were obtained from high-quality population-based cancer registries of four prefectures (Miyagi, Yamagata, Fukui and Nagasaki). Joinpoint regression analysis was performed to examine the trends in agestandardized rates of cancer incidence and mortality. Results: All-cancer mortality decreased from the mid-1990s, with an annual percent change of 21.3% (95% confidence interval: 21.4, 21.3), while all-cancer incidence continually increased from 1985, with an annual percent change of 0.7% (95% confidence interval: 0.6, 0.8). Major cancer sites, particularly the liver, colorectum and lung (males), showed a pattern of increasing incidence and mortality rates until the mid-1990s, stabilizing or decreasing thereafter. Stomach cancer showed a long-term decreasing trend for both incidence and mortality, while female breast cancer showed a continuously increasing trend. The incidence of prostate cancer, particularly at the localized stage, increased rapidly between 2000 and 2003, while that of mortality decreased from 2004. No changes were detected in the incidence or mortality for colorectal, female breast or cervical cancers after the establishment of national screening programs for these cancers. Conclusions: The analysis of cancer trends in Japan revealed a recent decrease in mortality and a continuous increase in incidence, which are considered to reflect changes in the underlying risk factors such as tobacco smoking and infection, and are partially explained by early detection and improved treatment.
INTRODUCTION
National estimates of cancer incidence in Japan are annually reported as an Epidemiology Note in the Japanese Journal of Clinical Oncology (1, 2) . These data are useful for monitoring the most recent status of cancer incidence in Japan; however, analytical approaches, such as trend and clinicalstage distribution analyses, have yet to be performed using the data. Although a trend analysis of cancer mortality in Japan was reported, the data were outdated, as 2004 was the most recent year examined (3) .
Recently, we developed and validated a method for the trend analysis of national cancer incidence using data from four prefectural cancer registries in Japan (4) . However, trend analysis of current cancer registry data using this method is needed to identify cancers with increasing or decreasing rates. In the USA, the American Cancer Society publishes an annual report on trends in cancer incidence and mortality based on the analysis of up-to-date data (5) . Here we present an updated report on the trends in cancer incidence and mortality in Japan and propose that this approach should serve as a model for future annual reports on the analysis of cancer trends in Japan.
METHODS

CANCER MORTALITY
The target population for determining cancer mortality was the entire Japanese population. We obtained the number of annual cancer deaths between 1958 and 2011 from published vital statistics (6) . We analyzed site-specific cancers and all cancers combined with reference to the International Classification of Diseases (ICD) version 10 codes.
Population data for the calculation of mortality rates were also obtained from published vital statistics.
CANCER INCIDENCE
The target population for determining cancer incidence was that of the Japanese prefectures Miyagi, Yamagata, Fukui and Nagasaki, which were selected because long-term, highquality data from population-based cancer registries were available between 1985 and 2007. The population coverage of the four prefectures from 1985 to 2007 averaged 4.7%. It was previously confirmed that the trends in mortality for major cancer sites in these prefectural populations were representative of national trends (4) . The previous study showed that the data quality of the four cancer registries was chronologically stable for the period between 1985 and 2004. Although we added data for recent 3 years in the present study, the quality indexes stayed stable (Fig. 1) ; the proportions of death certificate notification, death certificate only and microscopically verified cases were 14.5, 9.1 and 79.1%, respectively, for the period between 1985 and 2004 and 14.2, 9.4 and 78.8%, respectively, for the period between 1985 and 2007.
Data collection was conducted in 2010 for cancers diagnosed between 1985 and 1992, and in 2011 for cancers diagnosed between 1993 and 2007. Details of data collection and quality assessment were described in a previous study (4) . We analyzed site-specific cancers and all cancers combined with reference to the ICD-10 codes converted from ICD for Oncology version 2 or 3. Carcinoma in situ (CIS) was generally excluded from the tabulation of cancer incidence, although cases including CIS were analyzed for several cancer sites (esophagus, colorectum, lung, skin, breast (female), uterus and bladder). Population data were obtained from the Figure 1 . Trends in the quality indexes of cancer incidence data from four prefectures: Miyagi, Yamagata, Fukui and Nagasaki prefectures. DCO, death certificate only; DCN, death certificate notification; MV, microscopically verified; M/I, mortality to incidence. website managed by the Surveillance Division, Center for Cancer Control and Information Services, National Cancer Center, Japan (7).
STATISTICAL ANALYSIS
Annual age-standardized rates (ASRs; standardized to the 1985 model Japanese population) for cancer mortality and cancer incidence were calculated using data of the entire Japanese population and the four prefectures, respectively. We used a Joinpoint regression model (8) implemented in the Joinpoint Regression Program (Version 3.4.3) developed by the US National Cancer Institute. The Joinpoint method identifies changes in data trends by connecting several different line segments on a log scale at 'joinpoints'. The annual percent change (APC) and the corresponding 95% confidence interval (CI) were estimated for each line segment. In our Joinpoint analysis, the number of incidence or deaths was assumed to follow a Poisson distribution. The maximum number of joinpoints, minimum number of observations from a joinpoint to either end of the data and minimum number of observations between two joinpoints were set at four, three and four, respectively (default settings).
To identify the major sites of cancer contributing to the recent decrease in all-cancer mortality detected in the Joinpoint regression analysis, we calculated the degree of contribution for individual cancer sites as follows. First, we identified the 'last segment', which was defined as the period starting from the last joinpoint to the end of observation period (i.e. 2011), for the trend of all-cancer mortality. Secondly, we used a log-linear regression model to sitespecific cancer mortality rates during the 'last segment' and identified cancer sites that significantly decreased during this period. Thirdly for each cancer site exhibiting a significant decrease in mortality, we calculated the difference in the mortality rate between the first and last years of the 'last segment'. Finally, we summed the difference and calculated the proportion of each cancer site relative to the total difference. These steps were performed for the ASRs of mortality by sex. Table 1 shows the results of Joinpoint regression analysis on the trends in all-cancer mortality rates in Japan between 1958 and 2007. The combined ASRs of all-cancer mortality for males and females increased from the beginning of the observation period until the mid-1960s, decreased in the subsequent three decades, temporarily became stable in the mid-1990s and decreased again from 1996 through the end of the observation period. The most recent APC in the ASR was 21.3% for the period between 1996 and 2011. The sex-specific ASRs also decreased from 1996, with APCs of 21.6 and 21.1% for males and females, respectively. These patterns were similar for those ,75 years of age, showing APCs with slightly steeper decreases than those of all ages. Nearly 80% of the decrease in all-cancer mortality among males observed from 1996 was accounted for by a decrease in mortality rates for stomach, liver and lung cancers (37.4, 28.3 and 14.1%, respectively). For females, 72% of the decrease in all-cancer mortality from 1996 was due to a decrease in mortality rates for stomach, liver and gallbladder cancers (41.4, 16.9 and 14.0%, respectively). Colorectal cancer accounted for 10% of the decrease in all-cancer mortality for both males and females (7.2 and 11.4%, respectively). Tables 2 and 3 show the site-specific results of Joinpoint regression analysis of cancer mortality for males and females, respectively. Figure 2 shows the trends in ASRs of mortality for major cancer sites. The mortality rate of stomach cancer continuously decreased during the observation period for both males and females, with APCs of 23.2 and 23.8%, respectively, for the most recent period. Many of the major cancer sites, including the colorectum and liver for both males and females, and the lung and prostate for males, had a similar pattern of increasing mortality rates until the mid-1990s, at which point the ASRs stabilized or decreased. Notably, the ASRs of female breast cancer continuously increased from the mid-1960s to the end of observation period, with the most recent APC estimated to be 1.2%. The ASRs of uterine cancer rapidly decreased until the mid-1990s and continued to decrease slowly until 2009. However, the mortality rates of cancer of the cervix uteri and corpus began to increase from around 1990 and 1970, respectively. Among the other examined cancer sites, the following sites showed recent significant increases in the ASR of mortality, with APCs .1%: male brain and nervous system, and female pancreas and urinary organs other than the bladder. Table 4 shows the results of Joinpoint regression analysis on the trends in all-cancer incidence in the four selected prefectures in Japan. For both males and females, irrespective of the inclusion of those aged 75 years or older, the ASRs of all-cancer incidence continuously increased during the entire observation period (1985 -2007) , with APCs ,1%. When we included CIS, the APC values increased slightly. Tables 5 and 6 show the cancer site-specific results of Joinpoint regression analysis of cancer incidence for males and females, respectively, in the four prefectures. Figure 3 shows the trends in ASRs of incidence for major cancer sites. The incidence rate of stomach cancer continuously decreased from the beginning of the observation period (1985) , with APCs of 21.7 and 22.5% for males and females, respectively. Among females, the incidence rate continued to decrease until the end of the observation period (2007), whereas that among males decreased until 2005. The typical pattern observed for trends in mortality, namely, an increase until the mid-1990s followed by stable or decreasing rates thereafter, was also seen for the incidence of colorectum and liver cancers for males and females, and for lung cancer among males. The incidence rate of prostate cancer increased until 2000 with an APC of 5.1%, markedly jumped between 2000 and 2003 with an APC of 29.7% and then became stable. The incidence rate of female breast
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Cancer trends in Japan cancer, as was observed for mortality, continuously increased during the observation period, reaching an APC of 4.4% in the most recent period. The incidence rate of uterine cancer also increased from the mid-1990s, with an APC of 2.4%. Cervical cancer had a similar pattern, although the most recent increase was not significant. Cancer of the corpus uteri rapidly increased in incidence from 2004 with an APC of 13.7%. Among other cancer sites, the following showed recent increases with APCs .1%: oral cavity and pharynx, skin, ovary, kidney and urinary organs (excluding bladder), thyroid and malignant lymphoma. Figure 4 shows the trends in the proportion of cancers at the localized stage for major cancer sites. For all cancers combined, the proportion of localized cancers increased during the observation period, from 44% in 1993 to 52% in 2007. Colorectal cancer displayed a similar trend in the proportion of localized cancers, as was observed for all cancers combined. When CIS in the colorectum was included, the trend remained unchanged, although the absolute proportion of localized cancers increased by 10%. For stomach and female breast cancers, the proportion of localized cancers increased from 55% in 1993 to 60% or higher in 2007. When CIS for female breast cancer was included, the absolute percentage increased by 2 -4%. For lung cancer, the proportion of localized cancers seemed to increase during the observation period, but remained as low as 33%. For cervical cancer, the proportion of localized cancers remained stable at 50 and at 80% when CIS was included. For prostate cancer, the proportion of localized cancers rapidly increased, between 1997 and 2003, from 40 to 60% or higher.
DISCUSSION
We analyzed the trends in cancer incidence and mortality in Japan between 1958 and 2011 and between 1985 and 2007, respectively, and found that all-cancer mortality began to decrease from the mid-1990s, whereas all-cancer incidence continues to increase from 1985. Among major cancers, liver cancer contributed to the decrease in cancer mortality from the mid-1990s. The incidence of liver cancer was also characterized by a decrease beginning in the 1990s. In Japan, hepatocellular carcinoma (HCC) accounts for 90% of liver cancer cases. Approximately 76% of HCC is caused by chronic infection with hepatitis C virus (HCV) (9) . The positive rate of HCV infection has been rapidly decreasing in the generation born after the early 1930s (10) . Therefore, the decrease in liver cancer incidence and mortality observed in the present study can be interpreted as a result of the decreasing trend in HCV infection (11) . The positive rate of hepatitis B virus infection has also been decreasing after the generation born in 1940s. This might have accelerated the decrease in liver cancer incidence and mortality. However, the influence of HBV is considered to be small, because HBV accounts for only 17% of HCC in Japan, and the peak positive rate of HBV is much lower than that of HCV (9) . Regarding prognosis, the population-based survival rates of liver cancer patients increased statistically significantly between the periods of 1993 -1996 and 2000 -2002, which was interpreted as a result of improved diagnostic and therapeutic strategy for HCC (12, 13) . The decrease in liver cancer mortality from the late 1990s may have included this effect. Male lung cancer reached a peak in the mid-1990s for both incidence and mortality. As 70% of male lung cancer is reportedly due to active tobacco smoking (14) , the observed peaks in lung cancer incidence and mortality may be a result of the high smoking prevalence in the 1960s or the peak in per capita cigarette consumption in the 1970s (15) . Organized screening programs for lung cancer using chest X-rays and sputum cytology were initiated nationwide in Japan in 1987 (16) . A clinical study indicated that the prognosis of lung cancer patients improved between 1989 and 1999, which was interpreted as a combined effect of increased proportion and improved treatment of early stage cases (17) . A population-based study also showed a consistent result (12) . In the present study, the proportion of localized stage of lung cancer has been slowly increasing after 1993 (Fig. 4) , and a decrease in lung cancer mortality was observed after 1996 for males and between 1998 and 2003 for females (Tables 2 and 3 , respectively). These changes may have partially reflected the early detection and improved treatment. 
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Colorectal cancer also reached a peak in the mid-1990s for both incidence and mortality, indicating an association with preventive/risk factors. Although alcohol consumption, overweight/obesity and low physical activity are probable or established risk factors for colorectal cancer in Japan (18) , it is difficult to determine which of these factors dominantly influenced the trends in colorectal cancer, because the population attributable fraction of these factors is not as large as HCV infection for liver cancer or tobacco smoking for male lung cancer (19) . Organized screening programs for colorectal cancer based on the fecal occult blood test was started nationwide in Japan in 1992 (16) . Colorectal cancer incidence stopped increasing shortly after this year (in 1995 and 1996 for males and females, respectively), which might be interpreted as a result of early detection and resection of adenoma. However, a similar trend was observed for colorectal cancer including CIS, and no changes were observed around this period in the proportion of localized stage or CIS in colorectal cancer. Regarding prognosis, the survival rates of colorectal cancer did not change statistically significantly between the periods of 1993 -1996 and 2000 -2002 (12) .
Stomach cancer accounted for 40% of the decrease of all-cancer mortality from the mid-1990s. However, a decrease in both the incidence and mortality of stomach cancer was observed from the beginning of the observation period. This long-term decrease in stomach cancer incidence and mortality is likely due to a decrease in Helicobacter pylori infection for those born after 1950 (20) . Although decreased salt intake may also be a reason for the decline in stomach cancer incidence and mortality, its contribution is considered to be relatively small (19) . The accelerated decrease in stomach cancer mortality beginning around 1970 is reportedly a result of improved treatment strategies in combination with early detection by organized X-ray screening programs that were started nationwide in 1983 (16, 21) .
Female breast cancer showed no sign of decline for either incidence or mortality. Preventive/risk factors, such as longer exposure to endogenous sex hormones, overweight/ obesity and lower physical activity (18) , might have affected the increase in female breast cancer, although it remains unknown which factors are dominant. Organized screening programs for female breast cancer by clinical breast examination (CBE) started in 1987 in Japan, and mammography in combination with CBE has been adopted since 2000 (target ages were expanded from 50þ years old to 40þ years old in 2004) (16) . However, no changes in female breast cancer incidence or proportion of localized cancers were observed in the year following the initiation of these programs. According to the Comprehensive Survey of Living Conditions, a Japanese national survey based on selfadministered questionnaires, the breast cancer screening rate among females aged 40 years or older has been around 20% (19.8% in 2004, 20 .3% in 2007 and 24.3% in 2010) (22) . Regarding prognosis, the population-based survival rate of female breast cancer statistically significantly improved between the periods of 1997 -1999 and 2000 -2002, which was interpreted as an improvement of treatment (12) .
However, no decreases in mortality were observed during the same period in the present study.
The finding that the mortality of cervix and corpus uteri cancers began to increase around 1990 and 1970, respectively, should be interpreted with caution, because the proportion of cancer of the 'uterus, not otherwise specified (NOS)' has been continuously increasing in Japan. In spite of the decrease in cancer of the 'uterus, NOS', cervical cancer mortality showed long-term decreases starting between the late 1950s and late 1980s. In addition, the incidence of cervical cancer also decreased until late 1990s, a finding that may have resulted from improved hygiene. It is notable that the mortality of cervical cancer began to increase in 1989, particularly among women aged between 35 and 59 years, and that the incidence of cervical cancer stopped decreasing in the late 1990s. Organized screening programs for cervical cancer using pap smears were started nationwide in Japan in 1983 (16) . Though the incidence of cervical cancer including CIS continuously increased after 1985, both the incidence and mortality of invasive cervical cancer stopped decreasing in 1989 and 1997, respectively. Moreover, there were no 
502
Cancer trends in Japan (12) . The mortality rates of cancer of the corpus uteri have been increasing since the 1970s, a finding that likely indicates a shift from recording cancer of the 'uterus, NOS' to 'corpus uteri' in death certificates; however, the incidence of cancer of the corpus uteri also increased between 1985 and 1997, and after 2004. The incidence of prostate cancer in Japan rapidly increased between 2000 and 2003. As the proportion of localized prostate cancers also rapidly increased during these years, the increased incidence can be interpreted to be a result of early diagnosis by prostate specific antigen testing. The mortality rate of prostate cancer started to decrease in 2004, immediately after the increase in incidence, although the mortality rate appears to have started leveling off as early as the mid-1990s (Fig. 2) . Regarding prognosis, the population-based survival rate of prostate cancer improved statistically significantly between the periods of 1993 -1996 and 2000 -2002, which was interpreted as an improved prognosis for regional and distant stages (12) .
The Basic Plan to Promote Cancer Control Programs (Basic Plan) was developed by the national government of Japan in June 2007. The 10-year goal of this plan was a 20% reduction in the ASR of all-cancer mortality below the age of 75 years. In the first 5 years since the Basic Plan was implemented, the APC in the ASR was 1.9 (95% CI: 22.2, 21.6). At this rate, the 10-year goal of the plan would be realized. However, our Joinpoint regression analysis did not detect any joinpoints after the baseline year of the Basic Plan, which indicates that the rate of cancer mortality decrease has not changed after implementation of the Basic Plan. To accelerate the decrease in all-cancer mortality, effective cancer control policies, such as tobacco control, evidence-based cancer screening and equalization of cancer care, need to be further promoted.
There are a few limitations in the present study. First, the trends in cancer incidence were analyzed using data collected in four prefectures, whose populations comprise 4.7% of the total Japanese population. Although the representativeness of the data was confirmed in a previous study for major cancers, an underestimation of the degree of the recent decline in female liver cancer was also reported (4). For minor cancers, it is possible that data from the four prefectures examined in the present study were not representative of the total Japanese population or that too few cases were analyzed to detect significant changes between years. Secondly, for both cancer incidence and mortality, we conducted trend analysis alone and provided only descriptive interpretations. However, many of the interpretations were based on previous literature using a more analytical framework.
In conclusion, our analysis of cancer trends in Japan revealed a recent decrease in mortality and a continuous increase in incidence. These trends are considered to be a result of changes in the underlying risk factors, such as tobacco smoking and infection, and are partially explained by early detection and improved treatment. 
